CN Patent

CN104017031A — 降血糖药物和组合物

Assigned to Beijing Kaili Economic And Trade Co Ltd · Expires 2014-09-03 · 12y expired

What this patent protects

本发明涉及降血糖药物和组合物。具体涉及式I所示化合物：或其溶剂合物，其结构如说明书所述。本发明还涉及包括所述化合物的药物组合物以及它们的用途。本发明化合物或组合物是一种优良的降血糖药。

USPTO Abstract

本发明涉及降血糖药物和组合物。具体涉及式I所示化合物：或其溶剂合物，其结构如说明书所述。本发明还涉及包括所述化合物的药物组合物以及它们的用途。本发明化合物或组合物是一种优良的降血糖药。

Drugs covered by this patent

Patent Metadata

Patent number
CN104017031A
Jurisdiction
CN
Classification
—
Expires
2014-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Kaili Economic And Trade Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.